Nanocarriers for the Delivery of Neuroprotective Agents in the Treatment of Ocular Neurodegenerative Diseases

Retinal neurodegeneration is considered an early event in the pathogenesis of several ocular diseases, such as diabetic retinopathy, age-related macular degeneration, and glaucoma. At present, there is no definitive treatment to prevent the progression or reversal of vision loss caused by photorecep...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Chirag, Pande, Sonal, Sagathia, Vrunda, Ranch, Ketan, Beladiya, Jayesh, Boddu, Sai H. S., Jacob, Shery, Al-Tabakha, Moawia M., Hassan, Nageeb, Shahwan, Moyad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052766/
https://www.ncbi.nlm.nih.gov/pubmed/36986699
http://dx.doi.org/10.3390/pharmaceutics15030837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052766/
https://www.ncbi.nlm.nih.gov/pubmed/36986699
http://dx.doi.org/10.3390/pharmaceutics15030837

Ejemplares similares